Description
JAK2 inhibitor V (Z3) is an inhibitor of JAK2 that exhibits anticancer activity. In erythroleukemia cells, this compound induces cell cycle arrest and suppresses cellular proliferation.
Product Unit Size | Cost | Quantity | Stock |
---|
JAK2 inhibitor V (Z3) is an inhibitor of JAK2 that exhibits anticancer activity. In erythroleukemia cells, this compound induces cell cycle arrest and suppresses cellular proliferation.
Cas No. | 195371-52-9 |
---|---|
Purity | ≥98% |
Formula | C23H24N2O |
Formula Wt. | 344.46 |
IUPAC Name | 2-Methyl-1-phenyl-4-(2-pyridinyl)-2-[2-(2-pyridinyl)ethyl]-1-butanone |
Synonym | JAK2 inhibitor V, Z3 |
Solubility | Soluble in DMSO or Ethanol |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Sayyah J, Magis A, Ostrov DA, et al. Z3, a novel Jak2 tyrosine kinase small-molecule inhibitor that suppresses Jak2-mediated pathologic cell growth. Mol Cancer Ther. 2008 Aug;7(8):2308-18. PMID: 18723478.
p110α PI3K inhibitor.
Antimicrobial peptide found in amphibians.
PKA substrate.
Fermentation impurity
PDE3 inhibitor.
Benzothiazole; TRPC5 agonist, PTR1 inhibitor, v...
Rapamycin impurity
Folic acid derivative
Peptide, involved in neutrophil activation; FPR...
Curcumin derivative; DNMT1 and α-amylase inhib...
Folic acid derivative
Triazole; 14-α demethylase inhibitor, voltage-...
Pyrimidine analog, fluorouracil derivative; thy...
δ2OR antagonist.
Antimicrobial peptide found in Vespula lewisii,...
Resveratrol prodrug; potential SIRT1 activator....
5-HT1A and σ1/2 agonist, 5-HT2A/2C/6/7, D1-4, ...
S-enantiomer of citalopram; SERT inhibitor.
NSAID; COX-2 inhibitor.
Inert clozapine analog, activates specialized G...